January 2020 FDA Recall Drug by Avkare Inc.
D-0661-2020 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Avkare Inc. on January 7, 2020 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0661-2020

Reason for Recall
Failed Impurities/Degradation Specifications: High out of specification results for related compounds.
Initiated
01-07-2020
Reported
01-22-2020
Quantity
3,989 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the USA.
Dutasteride Capsules, 0.5 mg, 30 Capsules (6 X 5) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-282-13.

Batch or Lot Expiration Information

Lot# Lots: 25246, Exp. 02/2021; 24532, Exp. 10/2020; 23647, Exp. 06/2020